+199.3%
CBOE vs THC
+237.8%
-38.5%
-36.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | -0.2% | +0.2% | 0.0% |
| 7D | -4.7% | -8.0% | +3.3% | -4.3% |
| 30D | +12.2% | -2.2% | +14.4% | +12.3% |
| 3M | +22.0% | -3.5% | +25.4% | +22.2% |
| 6M | -0.4% | +40.4% | -40.8% | -2.3% |
| YTD | +43.6% | +32.4% | +11.1% | +40.9% |
| 1Y | +41.1% | +41.0% | +0.1% | +38.0% |
| 3Y | +108.1% | +305.2% | -197.1% | +84.6% |
| All | +199.3% | +237.8% | -38.5% | +169.6% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling